Prevalence of Microalbuminuria in Non-diabetic Hypertensive Patients and its Correlation with Changes in Left Ventricular and Left Atrial Characteristics
Related Experiment Video
Updated: Jul 21, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Khema Raj Bhusal1, Surya Devkota2, Surya Pathak3
1Tribhuwan University Teaching Hospital.
Background:
Microalbuminuria is urinary albumin excretion in the range of 30-300 mg per 24 hours and is considered as an abnormal albumin excretion rate. Microalbuminuria is associated with epithelial dysfunction and have a high risk for target organ damage resulting in stroke, retinopathy and adverse cardiovascular events. The objective of the study was to determine the prevalence of microalbuminuria in non-diabetic hypertensive patients and its correlation with cardiovascular changes.
Methods:
A quantitative cross-sectional study was done in 107 participants diagnosed as non-diabetic hypertensive patients visiting to Manmohan Memorial medical college and Teaching hospital and Manmohan Cardio-thoracic Vascular and transplant Centre. The assessed parameters were basic metabolic profile, urine evaluation and Echocardiography.
Results:
The results showed microalbuminuria in 28 study participants and not seen in 79 participants. Similarly, microalbuminuria was observed more comparable in those with presence of left ventricular hypertrophy as compared to the absence of left ventricular hypertrophy (29.3% versus 22.8%) (p value 0.469); those with presence of left ventricular diastolic dysfunction as compared to the absence of left ventricular diastolic dysfunction (31.1% versus 19%) (p value 0.170) and those with dilated left atrium as compared to normal left atrium (26.7% versus 23.9%) (p value 0.820). In case of left ventricular ejection fraction, those with normal left ventricular ejection fraction (26.3%) had slightly higher proportion of micro-albuminuria than those with mild to moderate left ventricular systolic dysfunction (20%) (p value= 0.755) Conclusions: There was no significant difference in the level of micro-albuminuria between non-diabetics, hypertensive patients with cardio vascular changes compared to patients with no cardiovascular changes.
Insights
Microalbuminuria, an early sign of kidney damage, was prevalent in non-diabetic hypertensive patients. However, this study found no significant correlation between microalbuminuria and cardiovascular changes in this population.
Area of Science:
- Nephrology
- Cardiology
- Hypertension Research
Background:
- Microalbuminuria (30-300 mg/24 hours) indicates abnormal albumin excretion and epithelial dysfunction.
- It is a risk factor for target organ damage, including stroke, retinopathy, and cardiovascular events.
- Early detection is crucial for managing associated risks.
Purpose of the Study:
- To determine the prevalence of microalbuminuria in non-diabetic hypertensive patients.
- To investigate the correlation between microalbuminuria and cardiovascular changes in this cohort.
Main Methods:
- A quantitative cross-sectional study involving 107 non-diabetic hypertensive patients.
- Assessed parameters included basic metabolic profile, urine evaluation, and echocardiography.
- Participants were recruited from Manmohan Memorial Medical College and Teaching Hospital.
Main Results:
- Microalbuminuria was detected in 28 participants (26.2%) and absent in 79 (73.8%).
- No significant differences in microalbuminuria prevalence were observed concerning left ventricular hypertrophy, diastolic dysfunction, left atrial size, or ejection fraction.
- Specific p-values indicated no statistical significance for these correlations.
Conclusions:
- The study found no significant association between microalbuminuria and cardiovascular changes in non-diabetic hypertensive patients.
- Further research may be needed to explore other potential contributing factors or markers in this population.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertension II: Pathophysiology
Heart Failure II: Pathophysiology
Nephrotic Syndrome II : Assessment and Medical Management
Hypertension and Regulation of Blood Pressure

